Which antiplatelet should we use in acute MI and why?

Written By: user Dr. Viveka Kumar
Published On: 18 Jan, 2022 5:44 PM | Updated On: 30 Oct, 2024 6:03 PM

Which antiplatelet should we use in acute MI and why?

In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will discuss which antiplatelet to use in acute MI. In acute MI, there are three antiplatelets apart from aspirin has to be combined. Clopidogrel and aspirin is the oldest drug but many patients are resistant to this combination. He will further explain that in acute MI if the patient has undergone angiography, then prasugrel and aspirin or ticagrelor and aspirin or aspirin and clopidogrel is used. He will also highlight that more preferably prasugrel or ticagrelor is used.

user
Dr. Viveka Kumar

Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.

 More FAQs by Dr. Viveka Kumar
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks